Lowndes Advises Applied DNA on EUA Amendment for Its COVID-19 Diagnostic Assay Kit Delivering Increased Accessibility and Turnaround Time to Customers


  • August 4, 2020
  • /   
  • /   Press Releases,Life Sciences
Man Reading Newspaper
Lowndes advised Applied DNA through the FDA Emergency Use Authorization (EUA) amendment process for its COVID-19 Diagnostic Assay Kit, which will expand availability and help meet demand during the pandemic.

Lowndes Advises Applied DNA on FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit


  • May 20, 2020
  • /   
  • /   Press Releases,Life Sciences
Man Reading Newspaper
Lowndes helped navigate Applied DNA through the FDA Emergency Use Authorization (EUA) process for the clinical use of the company’s patent-pending Linea™ COVID-19 RT-PCR test for COVID-19.